loading...| Preferred Name |
Hematologic complication of procedure |
|
| Synonyms |
Haematologic complication of procedure Hematologic complication of procedure (disorder) |
|
| ID |
http://purl.bioontology.org/ontology/SNOMEDCT/363135008 |
|
| Active |
1 |
|
| altLabel |
Haematologic complication of procedure Hematologic complication of procedure (disorder) |
|
| CASE SIGNIFICANCE ID |
900000000000448009 |
|
| CTV3ID |
XUPkB |
|
| cui |
C1285300 |
|
| DEFINITION STATUS ID |
900000000000073002 |
|
| Due to | ||
| Effective time |
20220228 |
|
| Has finding site | ||
| notation |
363135008 |
|
| Occurs after | ||
| prefLabel |
Hematologic complication of procedure |
|
| Subset member |
6011000124106~MAPTARGET~T81.89X? 6011000124106~MAPTARGET~C92.00 447562003~MAPRULE~TRUE 6011000124106~MAPPRIORITY~7 6011000124106~MAPPRIORITY~4 900000000000497000~MAPTARGET~XUPkB 6011000124106~MAPRULE~IFA 762315004 | Therapy related acute myeloid leukemia due to and following administration of antineoplastic agent | 6011000124106~MAPADVICE~MAP SOURCE CONCEPT CANNOT BE CLASSIFIED WITH AVAILABLE DATA 6011000124106~MAPTARGET~ 6011000124106~MAPCATEGORYID~447638001 6011000124106~MAPGROUP~1 6011000124106~MAPGROUP~2 6011000124106~MAPTARGET~T80.911? 6011000124106~MAPADVICE~IF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME RELATED TO ALKYLATING AGENT CHOOSE T45.1X5S | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT 447562003~MAPADVICE~MAP SOURCE CONCEPT CANNOT BE CLASSIFIED WITH AVAILABLE DATA 6011000124106~MAPADVICE~IF THERAPY RELATED ACUTE MYELOID LEUKEMIA DUE TO AND FOLLOWING ADMINISTRATION OF ANTINEOPLASTIC AGENT CHOOSE T45.1X5? | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | EPISODE OF CARE INFORMATION NEEDED | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT 6011000124106~MAPPRIORITY~8 6011000124106~MAPRULE~IFA 83250000 | Delayed hemolytic transfusion reaction | 6011000124106~MAPRULE~IFA 127319005 | Anemia due to alloimmune destruction of transfused red cells | 6011000124106~MAPRULE~IFA 766045006 | Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent | 447562003~MAPGROUP~1 447562003~CORRELATIONID~447561005 6011000124106~MAPADVICE~IF DELAYED HEMOLYTIC TRANSFUSION REACTION CHOOSE T80.911? | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | EPISODE OF CARE INFORMATION NEEDED | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT | POSSIBLE REQUIREMENT FOR AN EXTERNAL CAUSE CODE 6011000124106~MAPCATEGORYID~447637006 6011000124106~MAPTARGET~T45.1X5? 6011000124106~MAPTARGET~C92.40 900000000000509007~ACCEPTABILITYID~900000000000548007 6011000124106~MAPADVICE~IF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME RELATED TO ALKYLATING AGENT CHOOSE D46.9 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT 6011000124106~MAPADVICE~ALWAYS D75.9 900000000000508004~ACCEPTABILITYID~900000000000548007 447562003~MAPTARGET~ 447562003~MAPPRIORITY~1 6011000124106~MAPTARGET~P61.9 6011000124106~MAPRULE~OTHERWISE TRUE 6011000124106~MAPPRIORITY~5 6011000124106~MAPADVICE~IF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME RELATED TO TOPOISOMERASE TYPE 2 INHIBITOR CHOOSE D46.9 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT 6011000124106~MAPADVICE~IF ANEMIA DUE TO ALLOIMMUNE DESTRUCTION OF TRANSFUSED RED CELLS CHOOSE T80.911? | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | EPISODE OF CARE INFORMATION NEEDED | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT | POSSIBLE REQUIREMENT FOR AN EXTERNAL CAUSE CODE 6011000124106~MAPCATEGORYID~447639009 6011000124106~MAPADVICE~IF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME RELATED TO TOPOISOMERASE TYPE 2 INHIBITOR CHOOSE C92.00 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT 6011000124106~MAPTARGET~C92.90 6011000124106~MAPADVICE~IF DIFFERENTIATION SYNDROME DUE TO AND FOLLOWING CHEMOTHERAPY CO-OCCURRENT WITH ACUTE PROMYELOCYTIC LEUKEMIA CHOOSE C92.40 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT 6011000124106~MAPADVICE~ALWAYS T81.89X? | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | EPISODE OF CARE INFORMATION NEEDED | POSSIBLE REQUIREMENT FOR AN EXTERNAL CAUSE CODE 6011000124106~MAPADVICE~IF AGE AT ONSET OF CLINICAL FINDING BEFORE 29.0 DAYS CHOOSE P61.9 | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT 6011000124106~MAPADVICE~IF THERAPY RELATED ACUTE MYELOID LEUKEMIA DUE TO AND FOLLOWING ADMINISTRATION OF ANTINEOPLASTIC AGENT CHOOSE C92.90 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT 6011000124106~MAPPRIORITY~1 6011000124106~MAPTARGET~D75.9 6011000124106~MAPTARGET~T45.1X5S 6011000124106~MAPPRIORITY~6 6011000124106~CORRELATIONID~447561005 6011000124106~MAPRULE~IFA 773537001 | Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukemia | 6011000124106~MAPRULE~IFA 445518008 | Age at onset of clinical finding (observable entity) | < 29.0 days 6011000124106~MAPTARGET~D46.9 6011000124106~MAPRULE~TRUE 6011000124106~MAPGROUP~3 6011000124106~MAPPRIORITY~3 6011000124106~MAPRULE~IFA 766046007 | Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor | 6011000124106~MAPPRIORITY~2 6011000124106~MAPADVICE~IF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME RELATED TO TOPOISOMERASE TYPE 2 INHIBITOR CHOOSE T45.1X5S | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT 447562003~MAPCATEGORYID~447638001 6011000124106~MAPADVICE~IF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME RELATED TO ALKYLATING AGENT CHOOSE C92.00 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT 6011000124106~MAPADVICE~IF DIFFERENTIATION SYNDROME DUE TO AND FOLLOWING CHEMOTHERAPY CO-OCCURRENT WITH ACUTE PROMYELOCYTIC LEUKEMIA CHOOSE T45.1X5? | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | EPISODE OF CARE INFORMATION NEEDED | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT |
|
| tui |
T046 |
|
| Type ID |
900000000000003001 900000000000013009 |
|
| subClassOf |
http://purl.bioontology.org/ontology/SNOMEDCT/312087002 |
| Delete | Mapping To | Ontology | Source |
|---|---|---|---|
| http://purl.bioontology.org/ontology/SCTSPA/363135008 | SCTSPA | CUI |